Violaine Safar

Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort data

Laurie H. Sehn, Mark Hertzberg, Stephen Opat et al. · Blood Advances · 2021 · 169 citations · Full text

R/r Dlbcl, Immunology, Pathology +18

Prolonged PFS after Autologous Stem Cell Transplantation in Follicular Lymphoma Patients: A Long-Term Retrospective Study.

Violaine Safar, Thomas Gastinne, Nöel Milpied et al. · Blood · 2008 · 168 citations

Interim [ ¹⁸ F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab

Violaine Safar, Jehan Dupuis, Emmanuel Itti et al. · Journal of Clinical Oncology · 2011 · 158 citations · Full text

Commercial <scp>anti‐CD19 CAR</scp> T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center

Pierre Sesques, Emmanuelle Ferrant, Violaine Safar et al. · American Journal of Hematology · 2020 · 130 citations · Full text

Cell Therapy, Immunology, Immunoediting +20

Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells

Pierre Sesques, Jérémie Tordo, Emmanuelle Ferrant et al. · Clinical Nuclear Medicine · 2021 · 78 citations